TECHNOLOGY IN CANCER RESEARCH & TREATMENT
Scope & Guideline
Transforming cancer care through innovative technology.
Introduction
Aims and Scopes
- Innovative Treatment Modalities:
The journal emphasizes the development and evaluation of novel treatment approaches, including targeted therapies, immunotherapies, and combination therapies aimed at improving efficacy in various cancer types. - Biomarker Discovery and Validation:
Research on identifying, validating, and utilizing biomarkers for cancer diagnosis and prognosis is a core area, facilitating personalized medicine strategies and improving patient stratification. - Radiotherapy Techniques and Innovations:
A significant focus is placed on advancements in radiotherapy, including novel delivery techniques, dosimetry, and the integration of imaging technologies to enhance treatment precision and minimize side effects. - Machine Learning and AI Integration:
The journal explores the application of machine learning and artificial intelligence in predicting treatment responses, optimizing therapeutic approaches, and enhancing diagnostic accuracy in oncology. - Molecular and Cellular Mechanisms:
Research on the underlying molecular and cellular mechanisms of cancer progression and treatment resistance is crucial, focusing on pathways, gene expression, and the tumor microenvironment. - Translational Research:
The journal promotes studies that translate laboratory findings into clinical applications, bridging the gap between research and practical treatment paradigms. - Multimodal Imaging Techniques:
A focus on the development and application of advanced imaging techniques for better detection, monitoring, and treatment planning in cancer care.
Trending and Emerging
- Integration of AI and Machine Learning:
There is an increasing trend in the application of AI and machine learning for predictive analytics, treatment personalization, and diagnostic accuracy, highlighting the importance of data-driven approaches in oncology. - Focus on Tumor Microenvironment and Immune Response:
Research exploring the tumor microenvironment, including immune cell interactions and immunotherapy responses, is gaining momentum, reflecting the importance of immune modulation in cancer treatment. - Personalized Medicine and Genomic Approaches:
A significant rise in studies focused on personalized medicine, including genomic profiling and targeted therapy based on individual patient characteristics, is evident, aligning with the shift towards more tailored cancer therapies. - Advanced Biomaterial Applications:
Innovations in biomaterials for drug delivery, imaging, and therapy are on the rise, showcasing their potential in enhancing treatment efficacy and minimizing side effects. - Nanotechnology in Cancer Treatment:
Research on nanotechnology applications in cancer diagnosis and treatment is increasingly prominent, indicating a growing interest in utilizing nanoscale materials for targeted therapy and imaging. - Exploration of Non-Coding RNAs:
The role of non-coding RNAs, including microRNAs and long non-coding RNAs, in cancer biology and therapy resistance is becoming a hot topic, reflecting their potential as biomarkers and therapeutic targets. - Use of Real-World Data and Outcomes Research:
There is a growing trend towards utilizing real-world data to assess treatment outcomes and patient experiences in cancer care, providing valuable insights beyond clinical trial settings.
Declining or Waning
- Traditional Chemotherapy Studies:
There is a noticeable decrease in studies focusing solely on traditional chemotherapy regimens without the incorporation of novel agents or combinatory approaches, reflecting a broader trend towards personalized and targeted therapies. - Basic Laboratory Studies Without Clinical Relevance:
Research that does not translate into clinical applications or lacks direct relevance to patient care is becoming less common, with a greater emphasis on translational and applied research. - Single-Agent Targeted Therapies:
Publications focusing exclusively on single-agent therapies without exploring combination strategies or resistance mechanisms are declining, as the complexity of cancer treatment necessitates multifaceted approaches. - Conventional Radiotherapy Techniques:
There is a diminishing interest in traditional radiotherapy techniques, with more attention shifting towards advanced modalities such as proton therapy and stereotactic body radiotherapy that promise better outcomes. - General Cancer Epidemiology Studies:
Research that solely focuses on cancer epidemiology without a technological or interventional aspect is less frequently published, indicating a shift towards studies that involve direct technological applications.
Similar Journals
Cancer Biology & Medicine
Bridging Knowledge Gaps in OncologyCancer Biology & Medicine is a distinguished Open Access journal published by the China Anti-Cancer Association, dedicated to advancing research and understanding in the fields of Cancer Research and Oncology. Since its inception in 2012, the journal has provided a vital platform for the dissemination of high-quality research, evidenced by its impressive ranking within the Q1 and Q2 categories of oncology and cancer research as of 2023. With a significant impact factor and a Scopus ranking of #64 in Medicine/Oncology and #55 in Biochemistry, Genetics, and Molecular Biology, it plays a crucial role in shaping the future of cancer biology. By offering open access to its content, the journal ensures that pivotal research findings are readily available to researchers, professionals, and students globally, thereby fostering collaboration and innovation in cancer research. Situated in Tianjin, China, this journal is poised at the frontier of oncology research, making a significant impact through its rigorous peer-reviewed articles that address critical challenges in the field.
Turk Onkoloji Dergisi-Turkish Journal of Oncology
Advancing cancer research through collaboration and insight.Turk Onkoloji Dergisi - Turkish Journal of Oncology, published by KARE PUBL, serves as a vital platform in the field of oncology, specifically catering to the Turkish-speaking research community and contributing to global discourse. With an ISSN of 1300-7467, this journal, which has been in circulation since 2007 and continues until 2024, recognizes the importance of advancing medical knowledge in cancer research through rigorous peer-reviewed articles. Although currently positioned in the Q4 category of oncology journals with a Scopus rank of #344 out of 404, the journal is dedicated to fostering significant research insights and innovative perspectives on cancer treatment and prevention. While it does not currently offer open access, its content is essential for professionals, researchers, and students aiming to enhance their understanding of oncology developments in Turkey and beyond. The Turkish Journal of Oncology not only aspires to improve the quality of cancer care but also strives to enhance collaboration among researchers, thereby influencing future oncology practices.
CANCER BIOLOGY & THERAPY
Transforming cancer treatment through cutting-edge research.CANCER BIOLOGY & THERAPY is a premier open-access journal published by Taylor & Francis Inc, dedicated to advancing the field of cancer research and treatment. Since its inception in 2002, the journal has evolved to provide a platform for innovative research and groundbreaking findings, addressing critical aspects of cancer biology, pharmacology, and molecular medicine. With an impressive impact factor and recognition as a Q2 journal in vital categories such as Cancer Research, Oncology, and Pharmacology, it holds significant standing in Scopus rankings, reflecting its influence and commitment to disseminating high-quality research. Offering researchers, professionals, and students a wealth of knowledge, CANCER BIOLOGY & THERAPY stands at the forefront of the fight against cancer, presenting the latest developments and therapeutic strategies vital for improving patient outcomes. Accessible to all since 2022, this journal is a must-read for anyone involved in the multifaceted arena of cancer research and treatment.
ONCOLOGY RESEARCH
Exploring Innovative Strategies for Cancer TreatmentONCOLOGY RESEARCH, published by TECH SCIENCE PRESS, is a vital academic journal dedicated to the rapidly evolving field of oncology. With its ISSN 0965-0407 and E-ISSN 1555-3906, the journal serves as a key resource for researchers, clinicians, and academicians committed to advancing cancer research and treatment strategies. Operating without an Open Access model, ONCOLOGY RESEARCH provides high-quality, peer-reviewed articles that cover diverse topics within cancer research, medicine, and oncology, with its 2023 Scopus ranking placing it in the Q3 quartile. The journal's commitment to facilitating rigorous scientific discourse is evident in its historical breadth, with a publishing history dating back to 1992. ONCOLOGY RESEARCH is not only significant for the academic community but also plays a critical role in fostering new insights and approaches in the fight against cancer, making it a must-read for those involved in this critical area of study.
LANCET ONCOLOGY
Transforming the landscape of cancer treatment and prevention.The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.
Molecular & Cellular Oncology
Connecting researchers to the forefront of oncology.Molecular & Cellular Oncology, published by Taylor & Francis Inc, is a vital academic journal dedicated to the exploration of cancer biology through the lens of molecular and cellular mechanisms. Since its inception in 2014, the journal has played a crucial role in disseminating innovative research findings that address the fundamental aspects of cancer research and molecular medicine. With its current ranking in Scopus placing it in the Q3 quartile for both Cancer Research and Molecular Medicine, the journal provides a platform for groundbreaking studies that push the boundaries of our understanding of oncogenesis and therapeutic interventions. Although the journal operates under a subscription model, its dedication to high-quality peer-reviewed research makes it an essential resource for researchers, professionals, and students aiming to contribute to or stay updated in the rapidly evolving field of oncology. As we approach the culmination of its converged years in 2024, Molecular & Cellular Oncology aims to continue fostering collaborations and insights that advance cancer research on a global scale.
ANTICANCER RESEARCH
Innovating Strategies for Cancer CombatANTICANCER RESEARCH, published by the International Institute of Anticancer Research, stands at the forefront of cancer-related scholarly communication. With ISSN 0250-7005 and E-ISSN 1791-7530, this esteemed journal has been serving the global research community since 1981, showcasing innovative research aimed at combating cancer through various therapeutic approaches and scientific inquiry. Based in Greece, the journal aims to disseminate vital findings in the fields of Cancer Research, Medicine, and Oncology, reflecting its notable categorization in the Q3 and Q2 quartiles as of 2023. Despite its rigorous peer-review process and the absence of open access, ANTICANCER RESEARCH remains a vital publication for researchers, clinicians, and students eager to stay updated on the evolving landscape of anticancer strategies. As it converges to its milestone year of 2024, the journal continues to enrich the discourse around cancer treatment and prevention, affirming its position as an essential resource for those dedicated to advancing knowledge in anticancer therapies.
MOLECULAR CANCER THERAPEUTICS
Exploring the molecular mechanisms behind cancer therapies.MOLECULAR CANCER THERAPEUTICS, published by the American Association for Cancer Research, is a premier journal dedicated to advancing the field of cancer research and therapy since 2001. With a notable impact factor reflecting its high-quality content, this journal stands out in the Q1 category for both Cancer Research and Oncology as of 2023. Researchers, clinicians, and students interested in innovative treatment strategies and molecular mechanisms can find valuable insights within its pages, bolstered by a rigorous peer-review process and a global perspective on cancer therapeutic developments. Although the journal operates under a subscription model, it provides comprehensive access to cutting-edge studies and reviews that drive forward the understanding of cancer biology and treatment modalities. The journal's impressive Scopus rankings further validate its influence within both oncology and the broader cancer research community, making it an indispensable resource for anyone committed to combating cancer through science.
Translational Oncology
Advancing Cancer Research from Lab to LifeTranslational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.
npj Precision Oncology
Leading the Charge in Precision Oncology Researchnpj Precision Oncology, an esteemed peer-reviewed journal published by NATURE PORTFOLIO, stands at the forefront of oncological research and precision medicine. Launched as an Open Access platform in 2017, this journal not only facilitates the dissemination of innovative research findings but also ensures that crucial insights are freely accessible to the global scientific community. With an impressive ranking of Q1 in both Cancer Research and Oncology, and a commendable Scopus rank that places it in the top 15% of its field, npj Precision Oncology is dedicated to advancing our understanding of personalized cancer therapies through high-quality research. Catering to professionals, researchers, and students alike, this journal aims to bridge the gap between laboratory science and clinical application, paving the way for transformative approaches in oncology. As the landscape of cancer treatment evolves, npj Precision Oncology remains a crucial platform for fostering collaboration and sparking ideas that can significantly impact patient care.